# ALLEVIATE-HF-HD Study

> **NCT05501652** · PHASE1 · COMPLETED · sponsor: **Alleviant Medical, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** ALV1System

## Key facts

- **NCT ID:** NCT05501652
- **Lead sponsor:** Alleviant Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2022-08-22
- **Final completion:** 2023-02-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05501652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05501652, "ALLEVIATE-HF-HD Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05501652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*